Browse > Article

Inhibitory Effect of Coicis Semen Composition on Inflammatory Responses in the Collagen-induced Arthritis Mouse Model  

Moon, Jung-Won (Department of Oriental Medicine, Oriental Rehabilitation Medicine Daejeon University)
Oh, Min-Suck (Department of Oriental Medicine, Oriental Rehabilitation Medicine Daejeon University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.20, no.5, 2006 , pp. 1311-1314 More about this Journal
Abstract
This study was peformed to investigate possible mechanisms underlying possible effect of Coicis Semen composition (CSC) on inflammatory diseases using in vivo model of RA in the mice. Results are summarized as follows. In production of inflammatory cytokines, INF-${\gamma}$ in the spleen and IL-6 in the serum were decreased by CSC treatment. TNF-${\alpha}$ in serum was significantly decreased, IL-4 in the spleen was significantly increased by CSC treatment. In production of rheumatoid factors, IgM and IgG were significantly decreased by CSC treatment. The present data suggest that CSC treatment can improve pathological damage by CIA. So we expect that CSC should be used as a effective drugs for not only rheumatoid arthritis but also another autoimmune disease. Therefore we have to survey continuously in looking for the effective substance and mechanism in the future.
Keywords
Coicis Semen composition; Rheumatoid arthritis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Aho, K., Koskenvuo, M., Tuominen, J., Kaprio, J. Occurrence of rheumatoid arthritis in a nationwide series of twins, J Rheumatol, 13(5):899-902, 1986
2 Blaschke, S., Middel, P., Dorner, B.G., Blaschke, V., Hummel, K.M. and Kroczek, R.A., Reich, K., Benoehr, P., Koziolek, M., Muller, G.A. Expression of activation-induced, T cell-derived and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis, Arthritis Rheum, 48:1858-1872, 2003   DOI   ScienceOn
3 Morand, E.F., Bucala, R., Leech, M. Macrophage migration inhibitory factor; an emerging therapeutic target in rheumatoid arthritis, Arthritis Rheum, 48:291-299, 2003   DOI   ScienceOn
4 Setty, A.R., Sigal, L.H. Herbal medications commonly used in the practice of rheumatology; mechanisms of action efficacy and side effects, Semin Arthritis Rheum, 34(6):773-784, 2005   DOI   ScienceOn
5 D.M. Lee, and M.E. Weinblatt, Rheumatoid arthritis, Lancet, 358:903-911, 2001   DOI   ScienceOn
6 Nouri, A.M., Panayi, G.S., Goodman, S.M. Cytokines and the chronic inflammation of rheumatic disease I, The presence of interleukin-1 in synovial fluids, Clin Exp Immunol, 55:295-302, 1984
7 Bradley, K., Scatizzi, J.C., Shamiyeh, E. Retinoblastoma suppression of matrix metalloproteinase-1 but not interleukin-6, though a p-38-dependent pathway in rheumatoid arthritis synovial fibroblasts, Arthritis Rheum, 50:78-87, 2004   DOI   ScienceOn
8 Joe, B., Griffiths, M.M., Remmers, E.F., Wilder, R.L. Animal models of rheumatoid arthritis and related inflammation, Curr Rheumatol Rep, 1(2):139-148, 1999   DOI   ScienceOn
9 Carson, D.A., Pasquali, J.L., Tsoukas, C.D., Fong, S., Slovin, S.F., Lawrance, S.K., Slaughter, L., Vaughan, J.H. Physiology and pathology of rheumatoid factors, Springer Semin Immunopathol, 4:161-179, 1981   DOI   ScienceOn
10 Di, Giovine, F.S., Nuki, G., Duff, G.W. Tumour necrosis factor in synovial exudates, Ann Rheum Dis, 47:768-772, 1988   DOI   ScienceOn
11 Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., Kishimoto, T. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody, Arthritis Rheum, 50:1761-1769, 2004   DOI   ScienceOn
12 Sayah, A. English JC 3rd, Rheumatoid arthritis, a review of the cutaneous manifestations, J Am Acad Dermatol, Aug; 53(2):191-209, 2005   DOI   ScienceOn
13 Sutton, B., Corper, A., Bonagura, V., Taussig, M. The structure and origin of rheumatoid factors [comment], Immunol Today, 21:177-183, 2000   DOI   ScienceOn
14 Nouri, A.M., Panayi, G.S., Goodman, S.M. Cytokines and the chronic inflammation of rheumatic disease I, The presence of interleukin-1 in synovial fluids, Clin Exp Immunol, 55:295-302, 1984
15 Tuomi, T., Palosuo, T., Aho, K. The distribution of class-specific rheumatoid factors is similar in rheumatoid and pre-illness sera, Scand J Immunol, 24:751-754, 1986   DOI   ScienceOn
16 Aho, K., Palosuo, T., Raunio, V., Puska, P., Aromaa, A., Salonen, J.T. When does rheumatoid disease start, Arthritis Rheum, 28:485-489, 1985   DOI   ScienceOn